AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32860964 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate-high dose corticosteroids (IHDC)
Number of subjects: 778
Study 32860964 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse dose corticosteroids (PDC)
Number of subjects: 778
Study 32860964 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 778
Study 32860964 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 778
Study 32860964 — intervention group
Group type: EXPERIMENTAL
Intervention: PDC
Number of subjects: 778
Study 34817191 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobenate-enhanced MRI (0.05 mmol/kg)
Number of subjects: 126
Study 34817191 — intervention group
Group type: COMPARATOR
Intervention: Gadoxetate-enhanced MRI (0.025 mmol/kg)
Number of subjects: 126
Study 34817191 — intervention group
Group type: EXPERIMENTAL
Intervention: Both gadobenate and gadoxetate
Number of subjects: 126
Study 33577800 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg once daily for 35 days
Number of subjects: 4000
Study 33577800 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4000
Study 35987309 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced hybrid closed loop (AHCL) system with adjusted settings
Number of subjects: 42
Study 35987309 — intervention group
Group type: COMPARATOR
Intervention: Control group with unchanged AHCL settings
Number of subjects: 42
Study 34253219 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative spinal orthosis (Group A)
Number of subjects: 90
Study 34253219 — intervention group
Group type: COMPARATOR
Intervention: No postoperative spinal orthosis (Group B)
Number of subjects: 90
Study 34429030 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 64
Study 34429030 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Selected Intensity Training (SSIT)
Number of subjects: 64
Study 34429030 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 64
Study 33906786 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial unicompartmental knee arthroplasty (UKA) in LM (+) group
Number of subjects: 125
Study 33906786 — intervention group
Group type: COMPARATOR
Intervention: Medial unicompartmental knee arthroplasty (UKA) in LM (−) group
Number of subjects: 125
Study 33906786 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiological evaluation of implant position and mechanical axis in LM (+) group
Number of subjects: 125
Study 33906786 — intervention group
Group type: COMPARATOR
Intervention: Radiological evaluation of implant position and mechanical axis in LM (−) group
Number of subjects: 125
Study 32575605 — intervention group
Group type: EXPERIMENTAL
Intervention: Noodles made from yellow pea
Number of subjects: 12
Study 36335191 — intervention group
Group type: EXPERIMENTAL
Intervention: Domagrozumab
Number of subjects: 120
Study 36335191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 32144319 — intervention group
Group type: EXPERIMENTAL
Intervention: Lab4P probiotic (50 billion/day)
Number of subjects: 220
Study 34609303 — intervention group
Group type: COMPARATOR
Intervention: Proton-pump-based triple therapy (PpTT) for 2 weeks
Number of subjects: 400
Study 34609303 — intervention group
Group type: COMPARATOR
Intervention: Sequential therapy for 2 weeks
Number of subjects: 400
Study 34609303 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton-pump-based triple therapy plus bovine lactoferrin for 2 weeks
Number of subjects: 400
Study 34609303 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential therapy plus bovine lactoferrin for 2 weeks
Number of subjects: 400
Study 33203627 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) plus 20 weeks of prednisolone
Number of subjects: 0
Study 33203627 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus 20 weeks of prednisolone
Number of subjects: 0
Study 36175293 — intervention group
Group type: EXPERIMENTAL
Intervention: Romifidine IV (80 μg kg–1 premedication, 40 μg kg–1 hour–1 maintenance, 20 μg kg–1 before recovery)
Number of subjects: 63
Study 36175293 — intervention group
Group type: EXPERIMENTAL
Intervention: Detomidine IV (15 μg kg–1 premedication, 5 μg kg–1 hour–1 maintenance, 2.5 μg kg–1 before recovery)
Number of subjects: 63
Study 36175293 — intervention group
Group type: EXPERIMENTAL
Intervention: Detomidine IV (15 μg kg–1 premedication, 5 μg kg–1 hour–1 maintenance, 5 μg kg–1 before recovery)
Number of subjects: 63
Study 34319275 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated peppermint oil 180 mg 3 times daily
Number of subjects: 180
Study 34319275 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 35943064 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-assisted Internet-delivered cognitive therapy for SAD (OSCA)
Number of subjects: 43
Study 35943064 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 43
Study 33857455 — intervention group
Group type: EXPERIMENTAL
Intervention: Staggered group (single desynchronised monthly payments)
Number of subjects: 194
Study 33857455 — intervention group
Group type: EXPERIMENTAL
Intervention: Split and staggered group (desynchronised payments split into two instalments per month)
Number of subjects: 194
Study 33857455 — intervention group
Group type: COMPARATOR
Intervention: Control group (monthly synchronised payments)
Number of subjects: 194
Study 32114475 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme hypofractionated radiotherapy with stereotactic body radiation therapy to 36.25 Gy/5# (7 to 10 days)
Number of subjects: 434
Study 32114475 — intervention group
Group type: COMPARATOR
Intervention: Moderate hypofractionation schedule of 68 Gy/25# over 5 weeks
Number of subjects: 434
Study 32114475 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival, prostate cancer specific survival, acute and late toxicities, quality of life, and out-of-pocket expenditure
Number of subjects: 434
Study 33068641 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline, oxygen, patient positioning, glucagon
Number of subjects: 0
Study 33068641 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline dosing and frequency
Number of subjects: 0
Study 33068641 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihistamines and corticosteroids
Number of subjects: 0
Study 33068641 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendations based on low-level evidence
Number of subjects: 0
Study 33068641 — intervention group
Group type: EXPERIMENTAL
Intervention: New evidence in the last decade
Number of subjects: 0
Study 34238042 — intervention group
Group type: EXPERIMENTAL
Intervention: HF with assertive community treatment (HF-ACT)
Number of subjects: 527
Study 34238042 — intervention group
Group type: EXPERIMENTAL
Intervention: HF with intensive case management (HF-ICM)
Number of subjects: 527
Study 34238042 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 527
Study 33157939 — intervention group
Group type: EXPERIMENTAL
Intervention: Clostridium butyricum (C butyricum)
Number of subjects: 150
Study 33157939 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus coagulans (B coagulans)
Number of subjects: 150
Study 33157939 — intervention group
Group type: EXPERIMENTAL
Intervention: Clostridium butyricum plus Bacillus coagulans (C butyricum + B coagulans)
Number of subjects: 150
Study 33157939 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 150
Study 36173415 — intervention group
Group type: EXPERIMENTAL
Intervention: Romosozumab 210 mg monthly for 12 months
Number of subjects: 3013
Study 36173415 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3013
Study 33395175 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver-impregnated fibrous hydrocolloid (SFH) dressings
Number of subjects: 70
Study 33395175 — intervention group
Group type: COMPARATOR
Intervention: Topical silver sulfadiazine (SS) cream
Number of subjects: 70
Study 33395175 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study 33529449 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU + IRT
Number of subjects: 219
Study 33529449 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU + mianserin
Number of subjects: 219
Study 33529449 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU + IRT + mianserin
Number of subjects: 219
Study 33529449 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 219
Study 32641367 — intervention group
Group type: EXPERIMENTAL
Intervention: Connectivity guided intermittent theta burst stimulation (cgiTBS)
Number of subjects: 368
Study 32641367 — intervention group
Group type: COMPARATOR
Intervention: Neuronavigated repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 368
Study 32641367 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rated depression, anxiety, psychosocial functioning, cognition and quality of life assessments
Number of subjects: 368
Study 32641367 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness, patient acceptability, safety, mechanism of action and predictors of response
Number of subjects: 368
Study 35529453 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term spinal cord stimulation (stSCS)
Number of subjects: 70
Study 35529453 — intervention group
Group type: COMPARATOR
Intervention: Pulsed radiofrequency (PRF)
Number of subjects: 70
Study 32814589 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal sperm migration in injection dishes (Group B)
Number of subjects: 1034
Study 32814589 — intervention group
Group type: COMPARATOR
Intervention: Conventional swim-up method (Group A)
Number of subjects: 1034
Study 35980316 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel dental gel containing 0.454% stannous fluoride and 2.6% EDTA
Number of subjects: 60
Study 35980316 — intervention group
Group type: COMPARATOR
Intervention: Dentifrice with 0.24% sodium fluoride
Number of subjects: 60
Study 33589269 — intervention group
Group type: EXPERIMENTAL
Intervention: H2SO4-etched PEEK with universal adhesive conditioning for 0 min
Number of subjects: 70
Study 33589269 — intervention group
Group type: EXPERIMENTAL
Intervention: H2SO4-etched PEEK with universal adhesive conditioning for 1 min
Number of subjects: 70
Study 33589269 — intervention group
Group type: EXPERIMENTAL
Intervention: H2SO4-etched PEEK with universal adhesive conditioning for 3 min
Number of subjects: 70
Study 33589269 — intervention group
Group type: EXPERIMENTAL
Intervention: H2SO4-etched PEEK with universal adhesive conditioning for 5 min
Number of subjects: 70
Study 33589269 — intervention group
Group type: COMPARATOR
Intervention: Untreated PEEK with acidic adhesive conditioning (all time points)
Number of subjects: 70
Study 35441210 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU/d vitamin D
Number of subjects: 118
Study 35441210 — intervention group
Group type: COMPARATOR
Intervention: 400 IU/d vitamin D
Number of subjects: 118
Study 35441210 — intervention group
Group type: COMPARATOR
Intervention: Reference group (400 IU/d, sufficient vitamin D)
Number of subjects: 118
Study 34556517 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenotification letter
Number of subjects: 500
Study 34556517 — intervention group
Group type: COMPARATOR
Intervention: No prenotification letter
Number of subjects: 500
Study 34732094 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Imagery (MI) training for 8 weeks
Number of subjects: 34
Study 34732094 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy training (Control) for 8 weeks
Number of subjects: 34
Study 33201376 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic surgery for T1 and borderline ovarian tumors
Number of subjects: 228
Study 33201376 — intervention group
Group type: COMPARATOR
Intervention: Robotic surgery for T2 and T3/4 tumors
Number of subjects: 228
Study 33201376 — intervention group
Group type: COMPARATOR
Intervention: Current data on robotic surgery
Number of subjects: 228
Study 33201376 — intervention group
Group type: COMPARATOR
Intervention: Willingness to participate in clinical studies
Number of subjects: 228
Study 32459643 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended smoking cessation treatment (n=130)
Number of subjects: 292
Study 32459643 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face smoking cessation treatment (n=162)
Number of subjects: 292
Study 32459643 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face mode of blended treatment
Number of subjects: 292
Study 32459643 — intervention group
Group type: EXPERIMENTAL
Intervention: Web mode of blended treatment
Number of subjects: 292
Study 34183740 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise
Number of subjects: 208
Study 34183740 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous-moderate exercise
Number of subjects: 208
Study 34183740 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 208
Study 35900287 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer clinical trials (CCTs) participation
Number of subjects: 9
Study 34798860 — intervention group
Group type: EXPERIMENTAL
Intervention: Vignette-based intervention aiming to reduce stigma and support help-seeking
Number of subjects: 0
Study 34798860 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified elements and avatar-choice techniques
Number of subjects: 0
Study 35346351 — intervention group
Group type: EXPERIMENTAL
Intervention: Text Messaging (TM)
Number of subjects: 0
Study 35346351 — intervention group
Group type: COMPARATOR
Intervention: Telephone Counseling (TC)
Number of subjects: 0
Study 34216396 — intervention group
Group type: EXPERIMENTAL
Intervention: MT + Best Medical Management (BMM)
Number of subjects: 107
Study 34216396 — intervention group
Group type: COMPARATOR
Intervention: BMM alone
Number of subjects: 107
Study 34216396 — intervention group
Group type: EXPERIMENTAL
Intervention: MT + BMM
Number of subjects: 107
Study 32575660 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based obesity prevention intervention
Number of subjects: 77
Study 32603632 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioural treatment (ICBT), 8-week treatment
Number of subjects: 59
Study 32603632 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 59
Study 32755610 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial neural network classifier for promoter identification
Number of subjects: 3
Study 32755610 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-species experiments
Number of subjects: 3
Study 35862120 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives (process- and outcome-based)
Number of subjects: 0
Study 35862120 — intervention group
Group type: COMPARATOR
Intervention: Standard education and support for hypertension management (Control)
Number of subjects: 0
Study 33501563 — intervention group
Group type: EXPERIMENTAL
Intervention: Local estrogen group (promestriene 3 × for a week)
Number of subjects: 98
Study 33501563 — intervention group
Group type: COMPARATOR
Intervention: Control group (no estrogen)
Number of subjects: 98
Study 32857610 — intervention group
Group type: EXPERIMENTAL
Intervention: Learn!Grow!Eat!Go! (LGEG)
Number of subjects: 1326
Study 32857610 — intervention group
Group type: EXPERIMENTAL
Intervention: Walk Across Texas (WAT!)
Number of subjects: 1326
Study 32857610 — intervention group
Group type: COMPARATOR
Intervention: Control (neither Garden nor PA intervention)
Number of subjects: 1326
Study 35726351 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual chest compression and decompression (MCCD) maneuver
Number of subjects: 105
Study 32730289 — intervention group
Group type: COMPARATOR
Intervention: Tape-on no tension (0KT)
Number of subjects: 15
Study 32730289 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate tape tension (ModKT)
Number of subjects: 15
Study 32730289 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal tape tension (MaxKT)
Number of subjects: 15
Study 36107429 — intervention group
Group type: EXPERIMENTAL
Intervention: MERM-observed therapy (digital medication event reminder monitor); 15-day TB medication supply dispensed with a MERM device.
Number of subjects: 109
Study 36107429 — intervention group
Group type: COMPARATOR
Intervention: Standard directly observed therapy (DOT); in-person therapy.
Number of subjects: 109
Study 34195988 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic drug monitoring (TDM) arm
Number of subjects: 80
Study 34195988 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control arm)
Number of subjects: 80
Study 32545056 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation therapy intervention
Number of subjects: 60
Study 32545056 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 36102943 — intervention group
Group type: EXPERIMENTAL
Intervention: High-titer convalescent plasma
Number of subjects: 1239
Study 36102943 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1239
Study 36227595 — intervention group
Group type: EXPERIMENTAL
Intervention: Warnings with teaspoons of added sugar disclosures
Number of subjects: 5005
Study 36227595 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning conditions (groups 6 and 7)
Number of subjects: 5005
Study 36227595 — intervention group
Group type: EXPERIMENTAL
Intervention: No claim or imagery condition (group 4)
Number of subjects: 5005
Study 36227595 — intervention group
Group type: COMPARATOR
Intervention: Control group (group 1)
Number of subjects: 5005
Study 36227595 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage juice disclosures
Number of subjects: 5005
Study 34102559 — intervention group
Group type: COMPARATOR
Intervention: Fortified group 0 (FG0) - 0 mg/100 g bLF
Number of subjects: 96
Study 34102559 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified group 1 (FG1) - 38 mg/100 g bLF
Number of subjects: 96
Study 34102559 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified group 2 (FG2) - 76 mg/100 g bLF
Number of subjects: 96
Study 32212584 — intervention group
Group type: EXPERIMENTAL
Intervention: Toxocara spp. eggs presence
Number of subjects: 103
Study 32212584 — intervention group
Group type: EXPERIMENTAL
Intervention: Other zoonotic parasites presence
Number of subjects: 103
Study 32212584 — intervention group
Group type: EXPERIMENTAL
Intervention: Taeniid eggs presence
Number of subjects: 103
Study 32212584 — intervention group
Group type: EXPERIMENTAL
Intervention: Ancylostoma spp. eggs presence
Number of subjects: 103
Study 35304932 — intervention group
Group type: EXPERIMENTAL
Intervention: Papaverine (0.12 mg/ml, 1 ml)
Number of subjects: 100
Study 35304932 — intervention group
Group type: COMPARATOR
Intervention: Heparin (2 units/ml, 1 ml)
Number of subjects: 100
Study 35304932 — intervention group
Group type: EXPERIMENTAL
Intervention: Papaverine (0.12 mg/ml, 1 ml) as rescue treatment
Number of subjects: 100
Study 33044684 — intervention group
Group type: EXPERIMENTAL
Intervention: ABP 798
Number of subjects: 256
Study 33044684 — intervention group
Group type: COMPARATOR
Intervention: Rituximab RP
Number of subjects: 256
Study 33596883 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Carnitine supplementation (1000 mg)
Number of subjects: 76
Study 33596883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 32468749 — intervention group
Group type: COMPARATOR
Intervention: 1st Generation Antipsychotics
Number of subjects: 350
Study 32468749 — intervention group
Group type: EXPERIMENTAL
Intervention: 2nd Generation Antipsychotics
Number of subjects: 350
Study 35218231 — intervention group
Group type: EXPERIMENTAL
Intervention: Foliglurax 10 mg
Number of subjects: 157
Study 35218231 — intervention group
Group type: EXPERIMENTAL
Intervention: Foliglurax 30 mg
Number of subjects: 157
Study 35218231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study 32034010 — intervention group
Group type: EXPERIMENTAL
Intervention: IHI Model as a strategy to implement a managed sepsis protocol
Number of subjects: 416
Study 35738494 — intervention group
Group type: EXPERIMENTAL
Intervention: Macitentan (endothelin-1 receptor antagonist)
Number of subjects: 0
Study 35738494 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34243806 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention
Number of subjects: 0
Study 33377921 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (5 μg/kg in 0.5 ml)
Number of subjects: 113
Study 33377921 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (0.5 ml)
Number of subjects: 113
Study 33342320 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg methylphenidate
Number of subjects: 0
Study 33342320 — intervention group
Group type: COMPARATOR
Intervention: Control group (no methylphenidate)
Number of subjects: 0
Study 32515124 — intervention group
Group type: EXPERIMENTAL
Intervention: Life-behavior-promotion care
Number of subjects: 42
Study 32515124 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 42
Study 35139488 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight-section Brocades
Number of subjects: 47
Study 35139488 — intervention group
Group type: COMPARATOR
Intervention: Cognitive training
Number of subjects: 47
Study 35139488 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Eight-section Brocades and Cognitive training)
Number of subjects: 47
Study 34048108 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical hypnosis
Number of subjects: 100
Study 34048108 — intervention group
Group type: COMPARATOR
Intervention: Pain education
Number of subjects: 100
Study 34048108 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain catastrophizing measured at the same time as pain
Number of subjects: 100
Study 34048108 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain catastrophizing measured at different times than pain
Number of subjects: 100
Study 32627599 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin G/Hydrocortisone (PenGH)
Number of subjects: 16
Study 32627599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 34881664 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-h class group
Number of subjects: 647
Study 34881664 — intervention group
Group type: COMPARATOR
Intervention: 20-min DVD group
Number of subjects: 647
Study 34881664 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (2-h class and 20-min DVD)
Number of subjects: 647
Study 34403608 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based information
Number of subjects: 102